Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pfizer Selects Sites for its Post-Merger Global R&D Network

This article was originally published in The Pink Sheet Daily

Executive Summary

Newly merged company will cut R&D staff by 15 percent, though timing is unclear.

You may also be interested in...



Pfizer To "Exit" Eight Manufacturing Sites And SIice Jobs In Six More

Pfizer now is assessing its Animal Health manufacturing sites, with announcements expected in late June.

Pfizer To "Exit" Eight Manufacturing Sites And SIice Jobs In Six More

Pfizer now is assessing its Animal Health manufacturing sites, with announcements expected in late June.

Pfizer's Global R&D Network: Rapid Integration Means Doing More With Less

Pfizer's new R&D site structure will establish East and West Coast innovation corridors in the U.S., a large, centralized Europe-based R&D hub in Sandwich, U.K., and a network of nine specialized laboratories around the world

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS068844

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel